Know Cancer

or
forgot password

Use of High Dose Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Relapsed or Resistant Hodgkin's Disease


N/A
N/A
70 Years
Not Enrolling
Both
Hodgkin Disease

Thank you

Trial Information

Use of High Dose Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Relapsed or Resistant Hodgkin's Disease


Use of High Dose Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Relapsed or
Resistant Hodgkin's Disease


Inclusion Criteria:

- adequate organ function

- recurrent HD Exclusion Criteria:- CNS disease

- no prior malignancy

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Overall survival

Principal Investigator

Sally Arai

Investigator Role:

Principal Investigator

Investigator Affiliation:

Stanford University

Authority:

United States: Institutional Review Board

Study ID:

BMT24

NCT ID:

NCT00186251

Start Date:

March 1998

Completion Date:

July 2005

Related Keywords:

  • Hodgkin Disease
  • Hodgkin Disease

Name

Location

Stanford University School of MedicineStanford, California  94305-5317